Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

NCT06096337 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

484

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent Atrial Fibrillation

Interventions

DEVICE: FARAPULSE™ Pulsed Field Ablation (PFA) System
DRUG: Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone

Sponsor

Boston Scientific Corporation